G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 193-203

  Morris, Gavin E ^a   Nelson, Carl P ^b   Everitt, Diane ^b   Brighton, Paul J ^a   Standen, Nicholas B ^b   Challiss, R A John ^b   Willets, Jonathon M ^a,b  

^a Reproductive Sciences Section   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Arrestin; G protein coupled receptor kinase; P2Y purinoceptor; Resistance artery; UTP

Indexed keywords

ARRESTIN 2; CALCIUM ION; DYE; G PROTEIN COUPLED RECEPTOR KINASE 2; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR; RETINA S ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BIOSENSOR; CALCIUM SIGNALING; CELL STIMULATION; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSFECTION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; ARRESTINS; BASE SEQUENCE; CALCIUM SIGNALING; G-PROTEIN-COUPLED RECEPTOR KINASE 2; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2Y; RECEPTORS, PURINERGIC P2Y2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; URIDINE TRIPHOSPHATE;

EID: 78650484856     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq249     Document Type: Article

References (28)

1. Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Puriner-gic Signal 2008;4:1-20.
2. Winter P, Dora KA. Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries. J Physiol 2007;582:335-347.
3. Von Kugelgen I, Haussinger D, Starke K. Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedeberg's Arch Pharmacol 1987;336:556-560.
4. Malmsjo M, Adner M, Harden TK, Pendergast W, Edvinsson L, Erlinge D. The stable pyrimidines UDPbS and UTPgS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol 2000; 131:51-56.
5. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006;58:281-341.
6. 2 receptors. Br J Pharmacol 2003;140: 1169-1176.
7. Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol 1996; 118:704-710.
8. Liu R, Gutierrez AM, Ring A, Persson AE. Nitric oxide induces resensitization of P2Y nucleotide receptors in cultured rat mesangial cells. J Am Soc Nephrol 2002;13: 313-321.
9. 2 nucleotide receptor. Mol Cell Biochem 2000;205:115-123.
10. Willets JM, Challiss RAJ, Nahorski SR. Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol Sci 2003;24:626-633.
11. Luttrell LM, Lefkowitz RJ. The role of b-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002;115:455-465.
12. ATP channels by protein kinase-A. J Physiol 2001;536:421-427.
13. Nelson CP, Nahorski SR, Challiss RAJ. Temporal profiling of changes in phosphatidyl-inositol 4,5-bisphosphate, inositol 1,4,5-trisphosphate and diacylglycerol allows comprehensive analysis of phospholipase C-initiated signalling in single neurons. J Neurochem 2008;107:602-615.
14. Morris GE, Nelson CP, Standen NB, Challiss RAJ, Willets JM. Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. Cardiovasc Res 2010;85:424-433.
15. 1 his-tamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells. Mol Endocrinol 2008;22:1893-1907.
16. Gitterman DP, Evans RJ. Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed. Br J Pharmacol 2000;131:1561-1568.
17. Erlinge D, Hou M, Webb TE, Barnard EA, Moller S. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 1998;248:864-870.
18. 2 nucleotide receptor signaling in human monocytic cells: activation, desensitiza-tion and coupling to mitogen-activated protein kinases. J Cell Physiol 2001;187: 196-208.
19. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 2006;110:415-432.
20. 1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons. J Biol Chem 2005;280:18950-18958.
21. q signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension. Am J Physiol 2007;293: H3072-H3079.
22. 1D-adrenergic receptor constriction. Am J Physiol 2008;295:H1695-H1704.
23. Willets JM, Mistry R, Nahorski SR, Challiss RAJ. Specificity of G protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell m3 muscar-inic acetylcholine receptor signaling. Mol Pharmacol 2003;64:1059-1068.
24. Willets JM, Brighton PJ, Mistry R, Morris GE, Konje JC, Challiss RAJ. Regulation of oxy-tocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscle. Mol Endocrinol 2009;23:1272-1280.
25. Eckhart AD, Ozaki T, Tevaearai H, Rockman HA, Koch WJ. Vascular-targeted over-expression of G protein-coupled receptor kinase-2 in transgenic mice attenuates b-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 2002;61:749-758.
26. Hoffmann C, Ziegler N, Reiner S, Krasel C, Lohse MJ. Agonist-selective, receptor-specific interaction of human P2Y receptors with b-arrestin-1 and -2. J Biol Chem 2008;283:30933-30941.
27. Kim J, Zhang L, Peppel K, Wu JH, Zidar DA, Brian L et al. b-Arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ Res 2008;103:70-79.
28. q/protein kinase Czpathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J Biol Chem 2009;284:11953-11962.